#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA676616	F	In vitro cytotoxicity against murine P388 doxorubicin resistant leukemia cell line	Mus musculus	5	ALA1127831	cell-based format	Scientific Literature
2.	ALA683783	F	Inhibitory concentration to reduce cell number to 50% in a panel of cultured, murine P388 leukemia (P388) cells.	Homo sapiens	1	ALA1135712	cell-based format	Scientific Literature
3.	ALA708757	F	Inhibitory activity against leukemia P388 cell line	Mus musculus	13	ALA1145964	cell-based format	Scientific Literature
4.	ALA708758	F	Median survival time per control mice with leukemia P388 at 100 mg/kg dose injected intraperitoneally	Mus musculus	3	ALA1124690	organism-based format	Scientific Literature
5.	ALA708759	F	Median survival time per control mice with leukemia P388 at 10 mg/kg dose injected intraperitoneally	Mus musculus	1	ALA1124690	organism-based format	Scientific Literature
6.	ALA708760	F	Median survival time per control mice with leukemia P388 at 12.5 mg/kg dose injected intraperitoneally	Mus musculus	4	ALA1124690	organism-based format	Scientific Literature
7.	ALA708761	F	Median survival time per control mice with leukemia P388 at 200 mg/kg dose injected intraperitoneally	Mus musculus	3	ALA1124690	organism-based format	Scientific Literature
8.	ALA708762	F	Median survival time per control mice with leukemia P388 at 20 mg/kg dose injected intraperitoneally	Mus musculus	1	ALA1124690	organism-based format	Scientific Literature
9.	ALA708763	F	Median survival time per control mice with leukemia P388 at 25 mg/kg dose injected intraperitoneally	Mus musculus	4	ALA1124690	organism-based format	Scientific Literature
10.	ALA708764	F	Median survival time per control mice with leukemia P388 at 400 mg/kg dose injected intraperitoneally	Mus musculus	3	ALA1124690	organism-based format	Scientific Literature
11.	ALA708765	F	Median survival time per control mice with leukemia P388 at 400 mg/kg dose injected a dose of 400 mg/kg	Mus musculus	6	ALA1124690	organism-based format	Scientific Literature
12.	ALA708766	F	Median survival time per control mice with leukemia P388 at 40 mg/kg dose injected intraperitoneally	Mus musculus	1	ALA1124690	organism-based format	Scientific Literature
13.	ALA708767	F	Median survival time per control mice with leukemia P388 at 50 mg/kg dose injected intraperitoneally	Mus musculus	4	ALA1124690	organism-based format	Scientific Literature
14.	ALA708768	F	Median survival time per control mice with leukemia P388 at 400 mg/kg dose injected a dose of 400 mg/kg	Mus musculus	1	ALA1124690	organism-based format	Scientific Literature
15.	ALA708769	F	Cytotoxicity was evaluated against leukemia P388 cell-line by MTT assay	Mus musculus	6	ALA1130842	cell-based format	Scientific Literature
16.	ALA708770	F	Cytotoxicity was evaluated against leukemia P388 cell-line by MTT assay; IA means Inactive	Mus musculus	2	ALA1130842	cell-based format	Scientific Literature
17.	ALA708771	F	In vivo antitumor activity of compound was tested as maximal increase in life span (ILSmax) against lymphocytic leukemia P388 in mice	Mus musculus	13	ALA1130788	organism-based format	Scientific Literature
18.	ALA708059	F	In vivo antitumor activity of compound was tested as maximal increase in life span (ILSmax) against lymphocytic leukemia P388 in mice; NT means not tested	Mus musculus	5	ALA1130788	organism-based format	Scientific Literature
19.	ALA708060	F	Compound was tested in vivo for antitumor activity against lymphocytic leukemia P388 in mice	Mus musculus	13	ALA1130788	organism-based format	Scientific Literature
20.	ALA709263	F	In vivo antitumor activity against murine lymphocytic leukemia P388 measured as percent increase in life span	Mus musculus	22	ALA1124897	organism-based format	Scientific Literature